Edition:
United States

People: Alnylam Pharmaceuticals Inc (ALNY.O)

ALNY.O on Nasdaq

52.83USD
29 Mar 2017
Change (% chg)

$0.75 (+1.44%)
Prev Close
$52.08
Open
$52.00
Day's High
$53.58
Day's Low
$51.38
Volume
926,735
Avg. Vol
1,143,000
52-wk High
$80.11
52-wk Low
$31.38

Maraganore, John 

Dr. John M. Maraganore, Ph.D., is Chief Executive Officer, Director of the Company. Dr. Maraganore also served as our President from December 2002 to December 2007. From April 2000 to December 2002, Dr. Maraganore served as Senior Vice President, Strategic Product Development at Millennium Pharmaceuticals, Inc., a biopharmaceutical company (now Millennium: The Takeda Oncology Company). Dr. Maraganore serves as the chairman of the board of directors of Agios Pharmaceuticals, Inc., a biotechnology company and as a member of the board of directors of bluebird bio, Inc., a biotechnology company.

Basic Compensation

Total Annual Compensation, USD 1,112,030
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 632,810
Fiscal Year Total, USD 1,744,840

Options Compensation

  Quantity Market Value
Exercisable 764,108 7,795,030.00
Unexercisable 357,206 2,292,970.00
Exercised 128,145 4,859,390.00
Name Fiscal Year Total

Michael Bonney

543,713

Barry Greene

1,396,110

John Maraganore

1,744,840

Michael Mason

846,094

Yvonne Greenstreet

5,987,360

Akshay Vaishnaw

1,534,830
As Of  30 Dec 2016